Co-Authors
This is a "connection" page, showing publications co-authored by Stefano Piaserico and Matteo Megna.
Connection Strength
0.103
-
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study. J Dermatolog Treat. 2020 Aug; 31(5):476-483.
Score: 0.053
-
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study. J Am Acad Dermatol. 2019 07; 81(1):273-275.
Score: 0.051